In summary, current study suggests that tetracycline inhibits caspase-1 activation in response to silica and ameliorates silica-induced pulmonary inflammation including IL-1ß production, thereby reducing lung injury and fibrotic lung remodeling. This evidence concerns the gene IL1B and inflammation.